desmosdumotin B analogs (University of North Carolina/National Cancer Institute/Kanazawa University)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedesmosdumotin B analogs (University of North Carolina/National Cancer Institute/Kanazawa University)
Drug Alias Nameanalogs of desmosdumotin B (University of North Carolina/National Cancer Institute/Kanazawa University)tubulin inhibitors (University of North Carolina/National Cancer Institute/Kanazawa University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina, Greensboro
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of North Carolina, GreensboroNational Cancer InstituteKanazawa University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A